Prognosis of patients with T1 low-grade urothelial bladder cancer treated with bacillus Calmette-Guérin immunotherapy

Radosław Piszczek(Wroclaw Medical University), Tomasz Szydełko(Wroclaw Medical University), Élisabeth Grobet-Jeandin(Sorbonne Université), Wojciech Krajewski(Wroclaw Medical University), Bartosz Małkiewicz(Wroclaw Medical University), Joanna Chorbińska(Wroclaw Medical University), David D‘Andrea(Medical University of Vienna), Juan Gómez Rivas(Medico), Riccardo Mastroianni(Surgical Specialties (Canada)), Andrea Gallioli(Puigvert Foundation), Keiichiro Mori(Jikei University School of Medicine), Benjamin Pradère, Diego M. Carrión(Hospital Universitario de Torrejón), Beatriz Gutiérrez Hidalgo(Hospital Clínico San Carlos), Agnieszka Hałoń(Wroclaw Medical University), Simone Albisinni(University of Rome Tor Vergata), Alessia Cimadamore(University of Udine), Gautier Marcq(Centre National de la Recherche Scientifique), Morgan Rouprêt(Sorbonne Université), José Daniel Subiela(Universidad de Alcalá), Łukasz Nowak(Wroclaw Medical University), Ekaterina Laukhtina(Sechenov University), Renate Pichler(Innsbruck Medical University), Shahrokh F. Shariat(Universitätszahnklinik Wien), Marco Moschini(Vita-Salute San Raffaele University), A. Masson-Lecomte(Université Paris Cité), Juan Palou(Universitat Autònoma de Barcelona), Sonia Bebane(Université Paris Cité), Murat Akand(KU Leuven), Andrea Mari(Azienda Ospedaliero-Universitaria Careggi), Francesco Del Giudice(Sapienza University of Rome), Jan Łaszkiewicz(Wroclaw Medical University), Javier Burgos Revilla(Universidad de Alcalá), Laura S. Mertens(Oncode Institute), Marko Babjuk(Charles University), Francesco Soria(Medical University of Vienna)
Minerva Urology and Nephrology
September 1, 2023
Cited by 9


Related Papers